SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IVX: IVAX Corporation
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
78 6 0 IVX
Emcee:  SI (no user) Type:  Unmoderated
Introduction Market Data Compact
This message board is intended for discussion of IVX: IVAX Corporation.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
78Ivax Corp, Now Teva Pharma Unit, Trades As TEVA DOW JONES NEWSWIRES March 3, 200Jim Oravetz-3/6/2006
77Teva Announces Final Results of Merger Consideration in Connection with Ivax AcqJim Oravetz-3/1/2006
76Teva,Ivax:FTC Review Continues,Buyout To Close Soon DOW JONES NEWSWIRES JanuaryJim Oravetz-1/10/2006
75EU Clears Israeli Drug Co Teva To Buy Ivax DOW JONES NEWSWIRES November 25, 200Jim Oravetz-11/28/2005
74IVAX 3Q Net Up 25% On Record Rev Of $617.7M DOW JONES NEWSWIRES November 8, 2005Jim Oravetz-11/9/2005
73IVAX Sees 3Q EPS 20c/Shr,Including 4c/Shr From Merger Chgs DOW JONES NEWSWIRES OJim Oravetz-10/24/2005
72Teva And IVAX Get FTC Request For Additional Info DOW JONES NEWSWIRES October 11Jim Oravetz-10/12/2005
71Ivax Insiders Make Healthy Investments By RUTH MANTELL WSJ INSIDERS AT IVAX REJim Oravetz-7/26/2005
70Teva Will Buy Ivax In $7.4 Billion Deal By LEILA ABBOUD Staff Reporter of THE Jim Oravetz-7/25/2005
69IVAX Begins Sale Of Generic OxyContin As Authorized Distributor DOW JONES NEWSWIJim Oravetz-6/9/2005
68UPDATE:Ivax's Generic Antibiotic Not Affected By Injunction DOW JONES NEWSWIJim Oravetz-6/7/2005
67IVAX Gets Final Approval For Doxycycline Hyclate Tablets DOW JONES NEWSWIRES MayJim Oravetz-5/16/2005
66IVAX Reports 1Q 2005 Results; Rev Up 15.6% To $491.6 Million; Net Income $33.5 MJim Oravetz-4/28/2005
65FTC Rejects IVAX Claim On Generic Of Merck's Zocor DOW JONES NEWSWIRES AprilJim Oravetz-4/8/2005
64FDA To Phase Out Asthma Inhalers With CFCs By JENNIFER CORBETT DOOREN March 31,Jim Oravetz-4/2/2005
63Strong Generic Drug Makers Should Thrive By JOHANNA BENNETT BY BUYING Eon Labs Jim Oravetz-2/28/2005
62SemiOT:In Mexico, Maker of Generics Adds Spice to Drug Business Using Clinics aJim Oravetz-2/14/2005
61IVAX To Begin Marketing Gabapentin Capsules In March, Tablets In April, Prior ToJim Oravetz-2/11/2005
60Alpharma Expects Conclusion To Ivax Gabapentin Litigation DOW JONES NEWSWIRES FeJim Oravetz-2/3/2005
59IVAX To Meet Or Exceed Consensus Analysts' Views For 4Q 2004 DOW JONES NEWSWJim Oravetz-1/12/2005
582008 is a long time away, but still... Message 20940376tom pope-1/11/2005
57IVAX:Tentative Approval For Sertraline HCl(ZoloftTM) Tablets DOW JONES NEWSWIRESJim Oravetz-12/10/2004
56Ivax Dn 17% After 3Q EPS, Rev Missed Street Views DOW JONES NEWSWIRES November 1Jim Oravetz-11/3/2004
55Florida Atty General Subpoenas 6 Generic Drug Makers July 20, 2004 12:07 p.m. HoJim Oravetz-7/20/2004
54IVAX Announces Five-for-Four Stk Split DOW JONES NEWSWIRES July 15, 2004 MIAMI Jim Oravetz-7/20/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News